Morningstar

Straumann Holding AG STMN

Morningstar Rating
Unlock
Stock XSWX Rating as of
CHF 91.54 0.00 (0.00%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Straumann's Portfolio Strength and Commercial Prowess Drive Durable Above-Market Growth

Keonhee Kim

Straumann is a leader in the CHF 6 billion global dental implants industry. With decades of experience and unparalleled know-how, Straumann is frequently ranked as the most credible and trusted dental implant brand in the world. Today, the leading five companies hold about three quarters of the implant market, with the remaining space shared among several hundred local players.

Read Analysis

Price vs Fair Value

View History
STMN is trading at a LOCK|yDh!kw^ premium.
Price
CHF 91.54
Fair Value
LOCK|&h
Uncertainty
LOCK|%vF
1-Star Price
LOCK|l.Rx
5-Star Price
DPf
Economic Moat
LOCK|Q!^WC
Capital Allocation
LOCK|HdnK<$Z

Bulls Say, Bears Say

Bulls

Straumann's strategic tuck-in acquisitions add value in its growing portfolio and expand presence in high-growth emerging markets.

Bears

The value dental implant segment, an area Straumann lags relative to low-cost providers, could continue to outpace the premium segment and lead Straumann to lose its foothold in the implant market.

Show More

Trading Information

Previous Close Price
CHF 91.54
Day Range
CHF 90.38–92.88
52-Week Range
CHF 73.02–109.80
Bid/Ask
CHF 0.00 / CHF 93.40
Shares Outstanding
159.45M
Market Cap
CHF 14.60B
Volume/Avg
356,354 / 349,706

Key Statistics

Price/Earnings (Normalized)
28.02
Price/Sales
5.54
Dividend Yield (Trailing)
1.09%
Dividend Yield (Forward)
1.09%
Dividend Payment Schedule
Apr
Total Yield
1.51%

Company Profile

Straumann is a global leader in dental implants and orthodontics solutions. Its portolio includes abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it controls over one-third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Growth
Total Number of Employees
12,000
Website
https://www.straumann-group.com

Competitors

Valuation

View More
Metric
STMN
XRAY
ALGN
Price/Earnings (Normalized)
 28.026.1213.07
Price/Book Value
 6.401.292.45
Price/Sales
 5.540.482.52
Price/Cash Flow
 21.935.4010.66
Price/Earnings
STMN
XRAY
ALGN

Financial Strength

Metric
STMN
XRAY
ALGN
Quick Ratio
 1.610.721.20
Current Ratio
 2.261.631.40
Interest Coverage
 46.67−2.81—
Quick Ratio
STMN
XRAY
ALGN

Profitability

Metric
STMN
XRAY
ALGN
Return on Assets (Normalized)
 12.74%−0.14%12.71%
Return on Equity (Normalized)
 21.89%−0.54%19.67%
Return on Invested Capital (Normalized)
 18.37%1.64%18.83%
Return on Assets
STMN
XRAY
ALGN

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|t#MGf%^@LOCK|LSk$142B
 Becton Dickinson & Co
BDX
LOCK|mzLOCK|rBHC$49B
 ResMed Inc
RMD
LOCK|b!@D%jvLOCK|?^@!y$32B
 Medline Inc Ordinary Shares - Class A
MDLN
LOCK|>N%?nmLOCK|%#>?n$31B
 Alcon Inc
ALC
LOCK|#%t%@!LOCK|d<x@P$31B
 West Pharmaceutical Services Inc
WST
LOCK|@G!z@fjvLOCK|TL%$26B
 Solventum Corp
SOLV
LOCK|XznPkD!LOCK|Dt$15B
 Baxter International Inc
BAX
LOCK|bHLOCK|C>^?$$12B
 The Cooper Companies Inc
COO
LOCK|MD#GJ&LOCK|z#@#D$11B
 Align Technology Inc
ALGN
LOCK|b$$YzvLOCK|w%M>C$10B

Sponsor Center